Columbia University ( Site 0003) — New York, New York

Columbia University ( Site 0003) is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Columbia University ( Site 0003) has participated in 1 clinical trials.

Therapeutic areas: Solid Tumors, Lymphoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Columbia University ( Site 0003)?

Columbia University ( Site 0003) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Columbia University ( Site 0003) conducted?

Columbia University ( Site 0003) has 1 clinical trials on record. Their work covers Solid Tumors, Lymphoma.

Is Columbia University ( Site 0003) accredited by Crixeo Health?

Columbia University ( Site 0003) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Columbia University ( Site 0003)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.